XML 79 R72.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Equity Incentive Plan - Summary of Company's Outstanding Restricted Common Stock (Detail)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
USD ($)
$ / shares
shares
Jun. 30, 2024
USD ($)
$ / shares
shares
Schedule Of Nonvested Stock Option Activity [Line Items]    
Number of Restricted Shares, Granted   91,419
Expected future remaining compensation expense | $ $ 1,353 $ 1,353
Expected future compensation expense, restricted shares remaining vesting period   2 years 9 months 21 days
Restricted Shares Awarded on March 14, 2020 [Member]    
Schedule Of Nonvested Stock Option Activity [Line Items]    
Number of Restricted Shares, Granted   2,027
Date of Award   Mar. 14, 2020
Expected future remaining compensation expense | $ 19 $ 19
Expected future compensation expense, restricted shares remaining vesting period   6 months
Restricted Shares Awarded on March 3, 2021 [Member]    
Schedule Of Nonvested Stock Option Activity [Line Items]    
Number of Restricted Shares, Granted   4,944
Date of Award   Mar. 03, 2022
Expected future remaining compensation expense | $ 65 $ 65
Expected future compensation expense, restricted shares remaining vesting period   1 year 6 months
Restricted Shares Awarded on March 3, 2022 [Member]    
Schedule Of Nonvested Stock Option Activity [Line Items]    
Number of Restricted Shares, Granted   6,880
Date of Award   Mar. 03, 2022
Expected future remaining compensation expense | $ 130 $ 130
Expected future compensation expense, restricted shares remaining vesting period   2 years 6 months
Restricted Shares Awarded on March 3, 2022 [Member]    
Schedule Of Nonvested Stock Option Activity [Line Items]    
Number of Restricted Shares, Granted   5,139
Date of Award   Mar. 03, 2021
Expected future remaining compensation expense | $ 63 $ 63
Expected future compensation expense, restricted shares remaining vesting period   6 months
Restricted Shares Awarded on March 14, 2023 [Member]    
Schedule Of Nonvested Stock Option Activity [Line Items]    
Number of Restricted Shares, Granted   13,252
Date of Award   Mar. 14, 2023
Expected future remaining compensation expense | $ 232 $ 232
Expected future compensation expense, restricted shares remaining vesting period   3 years 6 months
Restricted Shares Awarded on March 14, 2023 [Member]    
Schedule Of Nonvested Stock Option Activity [Line Items]    
Number of Restricted Shares, Granted   18,371
Date of Award   Mar. 14, 2023
Expected future remaining compensation expense | $ 301 $ 301
Expected future compensation expense, restricted shares remaining vesting period   1 year 6 months
Restricted Shares Awarded on March 12, 2024 [Member]    
Schedule Of Nonvested Stock Option Activity [Line Items]    
Number of Restricted Shares, Granted   26,384
Date of Award   Mar. 12, 2024
Expected future remaining compensation expense | $ 349 $ 349
Expected future compensation expense, restricted shares remaining vesting period   4 years 6 months
Restricted Shares Awarded on March 12, 2024 [Member]    
Schedule Of Nonvested Stock Option Activity [Line Items]    
Number of Restricted Shares, Granted   14,422
Date of Award   Mar. 12, 2024
Expected future remaining compensation expense | $ $ 194 $ 194
Expected future compensation expense, restricted shares remaining vesting period   2 years 6 months
Restricted Stock [Member]    
Schedule Of Nonvested Stock Option Activity [Line Items]    
Number of Restricted Shares, Nonvested at beginning of period 91,419 85,670
Number of Restricted Shares, Granted 0 40,952
Number of Restricted Shares, Vested 0 (34,102)
Number of Restricted Shares, Forfeited 0 (1,101)
Number of Restricted Shares, Nonvested at end of period 91,419 91,419
Weighted Average Grant Date Fair Value, Nonvested at beginning of period | $ / shares $ 21.98 $ 21.88
Weighted Average Grant Date Fair Value, Granted | $ / shares 0 15.51
Weighted Average Grant Date Fair Value, Vested | $ / shares 0 18.34
Weighted Average Grant Date Fair Value, Forfeited | $ / shares 0 14.8
Weighted Average Grant Date Fair Value, Nonvested at end of period | $ / shares $ 21.98 $ 21.98